Cutaneous Vasculitis Associated With Vedolizumab in Ulcerative Colitis

Inflamm Bowel Dis. 2021 Jan 19;27(2):e15-e17. doi: 10.1093/ibd/izaa255.
No abstract available

Keywords: adverse events; biological therapy; ulcerative colitis; vedolizumab.

Publication types

  • Letter